C12Y 201/01043
Histone-lysine n-methyltransferase
Official title: Histone-lysine N-methyltransferase (2.1.1.43)
C12Y201/01043 (Histone-lysine n-methyltransferase) appears on 50 US grants and 92 published applications in this corpus.
Search patents in C12Y- Granted patents
- 50
- Published applications
- 92
- Assignees
- 47
- Inventors
- 157
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 1 | 2 |
| 2012 | 0 | 1 |
| 2013 | 0 | 3 |
| 2014 | 1 | 5 |
| 2015 | 2 | 5 |
| 2016 | 2 | 8 |
| 2017 | 4 | 5 |
| 2018 | 6 | 8 |
| 2019 | 4 | 11 |
| 2020 | 1 | 6 |
| 2021 | 5 | 4 |
| 2022 | 4 | 4 |
| 2023 | 6 | 8 |
| 2024 | 5 | 7 |
| 2025 | 3 | 5 |
| 2026 | 5 | 7 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods and compositions to increase somatic cell nuclear transfer (SCNT) efficiency by removing histone H3-lysine trimethylation2 Jun 2026US 12,644,133 B2Children's Medical Center Corporation
- Tumor antigen peptide26 May 2026US 12,637,500 B2Niigata University
- Therapy to stimulate hippocampal neural progenitors and adult neurogenesis31 Mar 2026US 12,589,109 B2University of Notre Dame du Lac
- Detection of molecular associations24 Feb 2026US 12,560,608 B2California Institute of Technology
- Methods and compositions for modulating gene expression13 Jan 2026US 12,522,823 B2Flagship Pioneering Innovations V, Inc.
- Detection of molecular associations1 Oct 2026US 2026/0298929 A1California Institute of Technology
- Novel inhibitors of histone methyltransferase nuclear localisation20 Aug 2026US 2026/0242753 A1The Council of the Queensland Institute of Medical Research
- Methods and compositions for modulating gene expression6 Aug 2026US 2026/0226464 A1Flagship Pioneering Innovations V, Inc.
- Antisense oligonucleotides targeting ezh2 splicing and their use for treating cancer and kidney disease23 Jul 2026US 2026/0209775 A1ASOcura Pharmaceuticals Suzhou Co., Ltd.
- Engineered CasPhi2 Nucleases28 May 2026US 2026/0146241 A1
Most cited
By later US patents
- Engineered CRISPR-Cas9 nucleases50US 9,926,546 B2The General Hospital Corporation · 2018
- Reconstituted histone methyltransferase complex and methods of identifying modulators thereof43US 7,563,589 B2The University of North Carolina at Chapel Hill · 2009
- Polycomb-associated non-coding RNAs31US 9,328,346 B2The General Hospital Corporation · 2016
- Diagnosis and treatment of cancer28US 9,040,286 B2Children's Medical Center Corporation · 2015
- Engineered CRISPR-Cas9 nucleases15US 10,526,591 B2The General Hospital Corporation · 2020